vTv Therapeutics Inc. (NASDAQ:VTVT – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $10.94 and last traded at $12.39, with a volume of 10477 shares. The stock had previously closed at $14.00.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of vTv Therapeutics in a research note on Sunday. They set a “hold” rating on the stock.
vTv Therapeutics Price Performance
Hedge Funds Weigh In On vTv Therapeutics
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Pathstone Family Office LLC acquired a new stake in shares of vTv Therapeutics in the 3rd quarter valued at $116,000. State Street Corp boosted its holdings in vTv Therapeutics by 268.7% in the second quarter. State Street Corp now owns 206,145 shares of the biotechnology company’s stock valued at $155,000 after purchasing an additional 150,228 shares in the last quarter. Prudential Financial Inc. purchased a new position in vTv Therapeutics in the second quarter valued at approximately $30,000. Finally, Millennium Management LLC lifted its position in shares of vTv Therapeutics by 12.0% during the 2nd quarter. Millennium Management LLC now owns 138,683 shares of the biotechnology company’s stock worth $104,000 after buying an additional 14,845 shares during the last quarter. Hedge funds and other institutional investors own 3.36% of the company’s stock.
vTv Therapeutics Company Profile
vTv Therapeutics Inc, a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company's lead drug candidate is TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis.
- Five stocks we like better than vTv Therapeutics
- What Are the FAANG Stocks and Are They Good Investments?
- Zoom Video Communications: A tech phoenix ready to rise
- Best Restaurant Stocks to Invest in Now
- The only two airline stocks worth buying: One is a Goldman pick
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ride the momentum: Apparel stocks soaring at 52-week highs
Receive News & Ratings for vTv Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for vTv Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.